| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/22/1993 | CN1076357A Pharmaceutical composition |
| 09/21/1993 | US5246708 Methods for promoting wound healing with deoxyribonucleosides |
| 09/21/1993 | CA2091942A1 Pharmaceutical composition |
| 09/19/1993 | WO1993018763A1 Compositions of n-(phosphonoacetyl)-l-aspartic acid and methods of their use as broad spectrum antivirals |
| 09/16/1993 | WO1993017715A1 Diagnostic and/or therapeutic agents, targeted to neovascular endothelial cells |
| 09/16/1993 | WO1993017713A1 Pharmaceutical composition having site-specific delivery |
| 09/16/1993 | WO1993017691A2 Pharmaceutical compositions containing monosialoganglioside gm1 or a derivative thereof suitable for the treatment of parkinson's disease |
| 09/16/1993 | WO1993017686A1 Estrogen/progestin/antiprogestin method and kit for oral contraception and regulating menses |
| 09/16/1993 | WO1993017685A1 Combinations of ace inhibitors and diuretics |
| 09/16/1993 | WO1993017672A1 Treatment of migraine |
| 09/16/1993 | WO1993017655A1 Topical aromatic releasing compositions |
| 09/16/1993 | WO1993017557A1 Cholesterol lowering compounds produced by directed biosynthesis |
| 09/16/1993 | CA2452130A1 Methods and compositions for targeting the vasculature of solid tumors |
| 09/16/1993 | CA2131990A1 Pharmaceutical composition having site-specific delivery |
| 09/15/1993 | EP0559845A1 Use of compounds in preventing endotoxin shock |
| 09/15/1993 | EP0559812A1 Composition containing antihistamine h 2? receptor antagonists and bioadhesive material |
| 09/15/1993 | EP0517836A4 Method and product for promoting hair growth and treating skin conditions |
| 09/14/1993 | US5244922 Methods for treating viral infections |
| 09/14/1993 | US5244913 Gallstones, quaternaty ammonium salts |
| 09/14/1993 | US5244902 Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses |
| 09/13/1993 | CA2091521A1 Method for producing carbohydrates |
| 09/08/1993 | EP0441833B1 Dosage form having reduced abuse potential |
| 09/08/1993 | EP0325613B1 Penetration enhancers for transdermal delivery of systemic agents |
| 09/07/1993 | US5242949 Treating classic migraine |
| 09/07/1993 | US5242941 Administering melatonin to adjust sleep cycle of humans |
| 09/07/1993 | US5242909 Anticarcinogenic agents and antitumor agents |
| 09/07/1993 | US5242824 Monoclonal antibody to human carcinomas |
| 09/07/1993 | CA1321994C Acylated uridine and cytidine and uses thereof |
| 09/02/1993 | WO1993016980A1 Cholesterol lowering compounds |
| 09/02/1993 | WO1993016733A1 Topical composition containing hyaluronic acid and nsaids |
| 09/02/1993 | WO1993016701A2 Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers |
| 09/02/1993 | WO1993016690A1 Cytoprotective compositions containing pyruvate and antioxidants |
| 09/02/1993 | WO1993016674A1 CoA-IT AND PAF INHIBITORS |
| 09/02/1993 | WO1993015112A3 COMPOUNDS AND METHODS FOR INHIBITING β-PROTEIN FUNCTION |
| 09/02/1993 | DE4205843A1 Medical use of 1-methyl-4-piperidyl di:phenyl-acetate - for prodn. of medicament for treating hypertonic bladder dysfunction |
| 09/02/1993 | CA2129732A1 Cytoprotective compositions containing pyruvate and antioxidants |
| 09/01/1993 | EP0557383A1 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
| 09/01/1993 | EP0557290A1 Treatment of aids dementia, myelopathy, peripheral neuropathy, and vision loss |
| 09/01/1993 | EP0316438B1 Chemical prevention or reversal of cataract by phase separation inhibitors |
| 08/31/1993 | US5240932 Percutaneously absorbable compositions of morphine or analogous analgesics of morphine |
| 08/31/1993 | US5240922 Fertility enhancement |
| 08/31/1993 | US5240917 Suppression of thromboxane levels by percutaneous administration of aspirin |
| 08/31/1993 | US5240696 Treatment of periodontitis |
| 08/31/1993 | US5240694 Combined antiviral and antimediator treatment of common colds |
| 08/25/1993 | EP0556880A2 Medical use for atypical beta-adrenoceptor agonists |
| 08/25/1993 | EP0556204A1 Pharmaceutical composition containing an ace inhibitor and an inhibitor of thromboxane a2 activity for treating nephropathies |
| 08/25/1993 | EP0556178A1 Use of protease nexin-i to mediate wound healing |
| 08/19/1993 | WO1993015768A1 Use of fullerenes in diagnostic and/or therapeutic agents |
| 08/19/1993 | WO1993015726A1 Compositions of clindamycin and benzoyl peroxide for acne treatment |
| 08/19/1993 | WO1993013741A3 Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors |
| 08/18/1993 | EP0555898A2 Medicaments for non-topical use |
| 08/18/1993 | EP0555681A1 Use of a combination of potassium channel activators and sulfhydryl containing compounds for the manufacture of a medicament for the treatment of ischemia and myocarolial infarct |
| 08/18/1993 | EP0555231A1 REGULATION OF NEOPLASTIC CELL PROLIFERATION VIA A NOVEL 5HT1a RECEPTOR |
| 08/18/1993 | EP0514452B1 Use of insulin sensitizing agents to treat hypertension |
| 08/18/1993 | EP0493485A4 Erection-inducing methods and compositions |
| 08/18/1993 | EP0339075B1 Acylated uridine and cytidine and uses thereof |
| 08/17/1993 | US5236933 Use of a combination of angiotensin-converting enzyme inhibitor and calcium antagonist for the treatment of proteinuria |
| 08/17/1993 | US5236904 Erection-inducing methods and compositions |
| 08/17/1993 | US5236714 Administering abuse substance in permeable form in conjunction with an antagonist in impermeable form; eliminates immediate "high" without diminishing therapeutic value |
| 08/17/1993 | US5236705 Fibrinolysis |
| 08/17/1993 | CA1321351C Method of dehydrating vesicle preparations for long-term storage |
| 08/14/1993 | CA2088455A1 Combination of potassium channel activator and sulfhydryl containing compound and methods of employing such combination |
| 08/11/1993 | EP0555116A2 Compositions based on antiseptics and their applications |
| 08/11/1993 | EP0447491B1 Protoporphyrinogen inhibitors and their use in compositions for detecting and treating tumours |
| 08/10/1993 | CA1321145C Pharmaceutical preparations |
| 08/10/1993 | CA1321144C Pharmaceutical preparations |
| 08/07/1993 | WO1994016563A1 1,2-dithiole-3-thiones for the treatment of reverse transcriptase-dependent viral infections |
| 08/05/1993 | WO1993015112A2 COMPOUNDS AND METHODS FOR INHIBITING β-PROTEIN FUNCTION |
| 08/05/1993 | WO1993014789A1 Pathogen-specific ctl therapy |
| 08/05/1993 | WO1993014787A1 Taxol as a radiation sensitizer |
| 08/05/1993 | CA2128693A1 Taxol as a radiation sensitizer |
| 08/04/1993 | EP0553777A2 Fast dissolving tablet and its production |
| 08/04/1993 | EP0553198A1 Regulation of immunoglobulin production by interleukin-9 |
| 08/04/1993 | EP0536119A4 Immunoregulatory agents |
| 08/04/1993 | EP0452416B1 Liquid orally administrable compositions based on edible oils |
| 08/03/1993 | CA1320904C Method for the treatment of atherosclerosis, thrombosis and peripheral vessel disease |
| 07/28/1993 | EP0552302A1 Method of inhibiting transcription utilizing nuclear receptors |
| 07/28/1993 | EP0458965A4 Process for the preparation of vinyl ethers |
| 07/28/1993 | EP0432199B1 Composition for the treatment of erectile dysfunction |
| 07/28/1993 | EP0381696B1 Pharmaceutical composition for the treatment of cocaine addiction |
| 07/27/1993 | US5231099 Use of sigma receptor antagonists to enhance the effects of antipsychotic drugs |
| 07/27/1993 | US5231085 Compositions and methods for the enhancement of host defense mechanisms |
| 07/27/1993 | US5230898 Transdermal therapeutic system exhibiting an increased active substance flow and process for the production thereof |
| 07/23/1993 | CA2087823A1 Medical use for atypical beta-adrenoceptor agonists |
| 07/22/1993 | WO1993013805A1 Cytotoxic drug therapy |
| 07/22/1993 | WO1993013801A1 Treatment for atherosclerosis |
| 07/22/1993 | WO1993013798A1 Treatment for asthma |
| 07/22/1993 | WO1993013741A2 Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors |
| 07/22/1993 | WO1993006852A3 Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
| 07/22/1993 | WO1993002693A3 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 07/21/1993 | EP0551442A1 Self-assembling ion pair drugs |
| 07/21/1993 | EP0551432A1 4,5,6,7-tetrahydro-1h-imidazo 4,5-c]pyridine derivatives and analogues as angiotensin ii receptor antagonists |
| 07/20/1993 | US5229379 Certain n-substituted-amino-alkane phosphinic acid derivatives having anti-epileptic properties |
| 07/20/1993 | CA1320449C Methods and compositions for thrombolytic therapy |
| 07/20/1993 | CA1320443C Liposomal vesicles for intraperitoneal administration of therapeutic agents |
| 07/14/1993 | EP0557290A4 Treatment of aids dementia, myelopathy, peripheral neuropathy, and vision loss. |
| 07/14/1993 | EP0551182A1 Method of treating hyperproliferative vascular disease using rapamycin, eventually in combination with mycophenolic acid |
| 07/14/1993 | EP0550702A1 METHODS FOR PREPARATION AND USE OF 1$g(a),24-DIHYDROXY VITAMIN D 2? |
| 07/14/1993 | EP0550668A1 Ibuprofen-antihistamine combinations |
| 07/14/1993 | EP0550663A1 Modified antibodies with controlled clearance time |